share_log

Nurix Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(6.18%),Deep Track Biotechnology Master Fund, Ltd.(6.18%), etc.

SEC announcement ·  Feb 14 08:58
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more